The use of BAY-11-7082-pretreated WT and Ndrg2−/− macrophages resulted in no differences between these two groups, suggesting that NF-κB pathway activation in Ndrg2−/− macrophages suppressed macrophage-mediated cancer cell migration (Fig. 7a). Here, NFKB1 is linked to cancer.